Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides

Reglodi, Dora; Renaud, Justine; Tamas, Andrea; Tizabi, Yousef; Socías, Sergio B.; Del-Bel, Elaine; Raisman-Vozari, Rita

doi:10.1016/j.pneurobio.2015.10.004

Cited by 162Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsNuclear Receptors and Signaling

Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides

Open access

Reglodi, Dora, Renaud, Justine, Tamas, Andrea, Tizabi, Yousef, Socías, Sergio B., Del-Bel, Elaine, Raisman-Vozari, Rita·2017·Progress in Neurobiology

DOI 10.1016/j.pneurobio.2015.10.004

Open this paper in CoChat — free account Open PDF

Abstract

Parkinson's disease is a progressive neurodegenerative disorder characterized by the degeneration of midbrain nigral dopaminergic neurons. Although its etiology remains unknown, the pathological role of several factors has been highlighted, namely oxidative stress, neuroinflammation, protein misfolding, and mitochondrial dysfunction, in addition to genetic predispositions. The current therapy is mainly symptomatic with l-DOPA aiming to replace dopamine. Novel therapeutic approaches are being investigated with the intention of influencing pathways leading to neuronal death and dysfunction. The present review summarizes three novel approaches, the use of which is promising in pre-clinical studies. Polyphenols have been shown to possess neuroprotective properties on account of their well-established antioxidative and anti-inflammatory actions but also due to their influence on protein misfolding and mitochondrial homeostasis. Within the amazing ancillary effects of antibiotics, their neuroprotective properties against neurodegenerative and neuroinflammatory processes are of great interest for the development of effective therapies against Parkinson's disease. Experimental evidence supports the potential of antibiotics as neuroprotective agents, being useful not only to prevent the formation of toxic α-synuclein oligomers but also to ameliorate mitochondrial dysfunction and neuroinflammation. Neuropeptides offer another approach with their diverse effects in the nervous system. Among them, pituitary adenylate cyclase-activating polypeptide, a member of the secretin/glucagon superfamily, has several advantageous effects in models of neurodegeneration, namely anti-apoptotic, anti-inflammatory and antioxidant actions, the combination of which offers a potent protective effect in dopaminergic neurons. Owing to their pleiotropic modes of action, these novel therapeutic candidates have potential in tackling the multidimensional features of Parkinson's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.pneurobio.2015.10.004

Cites

306 of 306 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Beta-lactams (cephalosporin antibiotics) have been shown to be effective in the treatment and alleviation of ND symptoms and in the treatment of experimentally induced neurological disorders such as PD, AD, ALS, traumatic brain injury, epilepsy, cerebral ischemia, and neuropathy.
“In particular, beta-lactams (cephalosporin antibiotics) have been shown to be effective in the treatment and alleviation of ND symptoms and in the treatment of experimentally induced neurological disorders such as PD, AD, ALS, traumatic brain injury (TBI), epilepsy, cerebral ischemia, and neuropathy (84, 117, 118).”
From Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis (2023) · cites this paper as [118]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Neurodegenerative Shielding by Curcumin and Its Derivatives on Brain Lesions Induced by 6-OHDA Model of Parkinson's Disease in Albino Wistar Rats
Agrawal, S. S., Gullaiya, S., Dubey, V., Singh, V., Kumar, A., Nagar, A., & Tiwari, P. (2012) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2012/942981 · Cited by 56 · see citing works
Retracted
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Rémésy, C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.230s · Cited by 4,219 · see citing works
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works
Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases
Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4581 · Cited by 2,601 · see citing works
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534 · see citing works
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · see citing works
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · see citing works
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · see citing works
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 1,906 · see citing works
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · see citing works
The substantia nigra of the human brain
Damier, P., Hirsch, É. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,772 · see citing works
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757 · see citing works
Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate
Franke, T. F., Kaplan, D., Cantley, L., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,609 · see citing works
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.
(1998) · Europe PMC (PubMed Central) · Cited by 1,594 · see citing works
Encapsulation of polyphenols – a review
Fang, Z., & Bhandari, B. (2010) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2010.08.003 · Cited by 1,570 · see citing works
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545 · see citing works
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 ( Tlr4 )
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525 · see citing works
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · see citing works
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P., Boyer, L. F., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,487 · see citing works
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. (2008) · Nature Structural &Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,424 · see citing works
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383 · see citing works
Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · see citing works
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · see citing works
Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,071 · see citing works
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
Vaudry, D., Falluel‐Morel, A., Bourgault, S., Basille, M., Burel, D., Wurtz, O., Fournier, A., Chow, B., Hashimoto, H., Galas, L., et al. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001370 · Cited by 1,060 · see citing works
Bioavailability of resveratrol
Walle, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05842.x · Cited by 1,051 · see citing works
Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · see citing works
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039 · see citing works
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Bieschke, J., Russ, J., Friedrich, R., Ehrnhoefer, D. E., Wobst, H. J., Neugebauer, K., & Wanker, E. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0910723107 · Cited by 986 · see citing works
Regulation of cap-dependent translation by eIF4E inhibitory proteins
Richter, J. D., & Sonenberg, N. (2005) · Nature · doi:10.1038/nature03205 · Cited by 972 · see citing works
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966 · see citing works
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Reeve, A. K., Simcox, E. M., & Turnbull, D. M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.01.004 · Cited by 961 · see citing works
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · see citing works
Direct Observation of the Interconversion of Normal and Toxic Forms of α-Synuclein
Cremades, N., Cohen, S. I. A., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, Á., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.037 · Cited by 901 · see citing works
Hierarchical phosphorylation of the translation inhibitor 4E-BP1
Gingras, A.-C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.912401 · Cited by 883 · see citing works
Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia
Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881 · see citing works
Role of Oxidative Stress in Parkinson's Disease
Hwang, O. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.1.11 · Cited by 845 · see citing works
Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity
Schinder, A. F., Olson, E. C., Spitzer, N. C., & Montal, M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06125.1996 · Cited by 770 · see citing works
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
Furth, P. A., St‐Onge, L., Boeger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H., & Hennighausen, L. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9302 · Cited by 768 · see citing works
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 755 · see citing works
Rapamycin blocks the phosphorylation of 4E‐BP1 and inhibits cap‐dependent initiation of translation.
Beretta, L., Gingras, A., Svitkin, Y. V., Hall, M. N., & Sonenberg, N. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00398.x · Cited by 673 · see citing works
Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease
Kim, Y. S., & Joh, T. H. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.40 · Cited by 655 · see citing works
The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention
Sheldon, A. L., & Robinson, M. B. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.012 · Cited by 593 · see citing works
Minocycline Provides Neuroprotection Against N -Methyl- d -aspartate Neurotoxicity by Inhibiting Microglia
Tikka, T., & Koıstınaho, J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7527 · Cited by 530 · see citing works
Antibiotics as signalling molecules
Yim, G., Wang, H. H., & Julian Davies, F. R. S. (2007) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2007.2044 · Cited by 496 · see citing works
Rapamycin Protects against Neuron Death inIn VitroandIn VivoModels of Parkinson's Disease
Malagelada, C., Jin, Z. H., Jackson-Lewis, V. R., Przedborski, S., & Greene, L. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 458 · see citing works
Minocycline and Neurodegenerative Diseases
Kim, H.-S., & Suh, Y.-H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.040 · Cited by 447 · see citing works
Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project
Kuriyama, S., Hozawa, A., Ohmori, K., Shimazu, T., Matsui, T., Ebihara, S., Awata, S., Nagatomi, R., Arai, H., & Tsuji, I. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.355 · Cited by 428 · see citing works
The Biological Relevance of Direct Antioxidant Effects of Polyphenols for Cardiovascular Health in Humans Is Not Established1–4
Hollman, P. C. H., Cassidy, A., Comte, B., Heinonen, M., Richelle, M., Richling, E., Serafini, M., Scalbert, A., Sies, H., & Vidry, S. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.131490 · Cited by 406 · see citing works
Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics
Kim, K., Lee, S., Kegelman, T. P., Su, Z.-Z., Das, S. K., Dash, R., Dasgupta, S., Barral, P. M., Hedvat, M., Diaz, P. W., et al. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22609 · Cited by 396 · see citing works
Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses
Sabroe, I., Jones, E. C., Usher, L. R., Whyte, M. K. B., & Dower, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4701 · Cited by 385 · see citing works
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection
Chung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., & Isacson, O. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi178 · Cited by 361 · see citing works
Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum
He, Y., Appel, S. H., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 350 · see citing works
Synergy effects of herb extracts: Pharmacokinetics and pharmacodynamic basis
Yang, Y., Zhang, Z., Li, S., Ye, X., Li, X., & He, K. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.10.010 · Cited by 345 · see citing works
Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation
Bureau, G., Longpré, F., & Martinoli, M. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21503 · Cited by 336 · see citing works
Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury
Teng, Y. D., Choi, H., Onario, R. C., Zhu, S., Desilets, F. C., Lan, S., Woodard, E. J., Snyder, E. Y., Eichler, M. E., & Friedlander, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306239101 · Cited by 335 · see citing works
Role of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 327 · see citing works
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss
Tain, L. S., Mortiboys, H., Tao, R. N., Ziviani, E., Bandmann, O., & Whitworth, A. J. (2009) · Nature Neuroscience · doi:10.1038/nn.2372 · Cited by 323 · see citing works
Induction of xenobiotic enzymes by the map kinase pathway and the antioxidant or electrophile response element (ARE/EpRE),†,‡
Kong, A., Owuor, E. D., Yu, R., Hebbar, V., Chen, C., Hu, R., & Mandlekar, S. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-120000652 · Cited by 318 · see citing works
Selective microglial activation in the rat rotenone model of Parkinson's disease
Sherer, T., Betarbet, R. S., Kim, J.-H., & Greenamyre, J. T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00172-1 · Cited by 317 · see citing works
Intranasal Treatment of Central Nervous System Dysfunction in Humans
Chapman, C. D., Frey, W. H., Craft, S., Danielyan, L., Hallschmid, M., Schiöth, H. B., & Benedict, C. (2013) · Pharmaceutical Research · doi:10.1007/s11095-012-0915-1 · Cited by 310 · see citing works
d-Cycloserine: A ligand for the coupled glycine receptor has partial agonist characteristics
Hood, W. F., Compton, R. P., & Monahan, J. B. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90379-0 · Cited by 309 · see citing works
Oxidative and nitrosative stress in Parkinson's disease
Tsang, A. H. K., & Chung, K. K. K. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.006 · Cited by 300 · see citing works
Novel pharmacological targets for the treatment of Parkinson's disease
Schapira, A. H. V., Bézard, E., Brotchie, J. M., Calon, F., Collingridge, G. L., Ferger, B., Hengerer, B., Hirsch, É. C., Jenner, P. G., Novère, N. G. L., et al. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2087 · Cited by 299 · see citing works
Free Radical Scavenging by Natural Polyphenols: Atom versus Electron Transfer
Meo, F. D., Lemaur, V., Cornil, J., Lazzaroni, R., Duroux, J., Olivier, Y., & Trouillas, P. (2013) · The Journal of Physical Chemistry A · doi:10.1021/jp3116319 · Cited by 295 · see citing works
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function
Ko, H. S., Lee, Y., Shin, J., Karuppagounder, S. S., Gadad, B. S., Koleske, A. J., Pletniková, O., Troncoso, J. C., Dawson, V. L., & Dawson, T. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006083107 · Cited by 286 · see citing works
The Flavanol (−)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity
Meng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P. (2010) · Biochemistry · doi:10.1021/bi100939a · Cited by 282 · see citing works
Minocycline as a Neuroprotective Agent
Stirling, D. P., Koochesfahani, K. M., Steeves, J. D., & Tetzlaff, W. (2005) · The Neuroscientist · doi:10.1177/1073858405275175 · Cited by 280 · see citing works
Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls
Ebrahimi, A., & Schluesener, H. J. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.01.006 · Cited by 276 · see citing works
Rapamycin protects against rotenone-induced apoptosis through autophagy induction
Pan, T., Rawal, P., Wu, Y., Xie, W., Jankovic, J. J., & Le, W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.014 · Cited by 272 · see citing works
α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
Lee, E.-J., Woo, M.-S., Moon, P., Baek, M., Choi, I.-Y., Kim, W.-K., Junn, E., & Kim, H.-S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903480 · Cited by 267 · see citing works
Neurodegeneration and Inflammation in Parkinson's disease
Phani, S., Loike, J. D., & Przedborski, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70064-5 · Cited by 263 · see citing works
Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson’s Disease
More, S. V., Kumar, H., Kim, I. S., Song, S.-Y., & Choi, D.-K. (2013) · Mediators of Inflammation · doi:10.1155/2013/952375 · Cited by 259 · see citing works
Molecular pathogenesis of Parkinson's disease
Gandhi, S., & Wood, N. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi308 · Cited by 251 · see citing works
Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., & Shimohama, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5 · Cited by 246 · see citing works
Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease
Ferretta, A., Gaballo, A., Tanzarella, P., Piccoli, C., Capitanio, N., Nico, B., Annese, T., Paola, M. D., Dell’Aquila, C., Mari, M. D., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.02.010 · Cited by 244 · see citing works
NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
Arima, K., Uéda, K., Sunohara, N., Arakawa, K., Hirai, S., Nakamura, M., Tonozuka-Uehara, H., & Kawai, M. (1998) · Acta Neuropathologica · doi:10.1007/s004010050917 · Cited by 239 · see citing works
Proteolytic Cleavage of Extracellular Secreted α-Synuclein via Matrix Metalloproteinases
Sung, J. Y., Park, S., Lee, C.-H., Um, J. W., Lee, H. J., Kim, J., Oh, Y. J., Lee, S., Paik, S. R., & Chung, K. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503341200 · Cited by 238 · see citing works
RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation
Malagelada, C., Jin, Z. H., & Greene, L. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3928-08.2008 · Cited by 228 · see citing works
Mitophagy
Tolkovsky, A. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.03.002 · Cited by 226 · see citing works
Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats
Karuppagounder, S. S., Madathil, S. K., Pandey, M., Haobam, R., Rajamma, U., & Mohanakumar, K. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.032 · Cited by 225 · see citing works
Curcumin Ameliorates the Neurodegenerative Pathology in A53T α-synuclein Cell Model of Parkinson’s Disease Through the Downregulation of mTOR/p70S6K Signaling and the Recovery of Macroautophagy
Jiang, T., Zhang, Y., Zhou, H., Wang, H., Tian, L., Liu, J., Ding, J., & Chen, S. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9431-7 · Cited by 220 · see citing works
Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils
Li, J., Zhu, M., Rajamani, S., Uversky, V. N., & Fink, A. L. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.025 · Cited by 218 · see citing works
Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6‐hydroxydopamine model of Parkinson’s disease
Marinova‐Mutafchieva, L., Sadeghian, M., Broom, L., Davis, J. B., Medhurst, A. D., & Dexter, D. T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06189.x · Cited by 217 · see citing works
Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway
Lou, H., Xu, J., Wei, X., Shi, H., Ren, D., & Zhang, X. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.11.026 · Cited by 212 · see citing works
Pituitary Adenylate Cyclase Activating Polypeptide: A Potential Neuroprotective Peptide
Somogyvári-Vigh, A., & Reglődi, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383548 · Cited by 207 · see citing works
Brain-Targeted Proanthocyanidin Metabolites for Alzheimer's Disease Treatment
Wang, J., Ferruzzi, M. G., Ho, L., Blount, J. W., Janle, E. M., Gong, B., Pan, Y., Gowda, G. A. N., Raftery, D., Arrieta‐Cruz, I., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6437-11.2012 · Cited by 206 · see citing works
Neuroprotection by tetracyclines
Domercq, M., & Matute, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.001 · Cited by 205 · see citing works
Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease?
Tolkovsky, A. M., Xue, L., Fletcher, G. C., & Borutaite, V. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01371-8 · Cited by 203 · see citing works
Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide
Gayle, D. A., Ling, Z., Tong, C. W., Landers, T. M., Lipton, J. W., & Carvey, P. M. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00315-7 · Cited by 201 · see citing works
Role of the Blood–Brain Barrier in the Nutrition of the Central Nervous System
Campos‐Bedolla, P., Walter, F. R., Veszelka, S., & Deli, M. A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.018 · Cited by 196 · see citing works
Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6.
Ohtaki, H., Nakamachi, T., Dohi, K., Aizawa, Y., Takaki, A., Hodoyama, K., Yofu, S., Hashimoto, H., Shintani, N., Baba, A., et al. (2006) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0600375103 · Cited by 195 · see citing works
The role of α-synuclein in neurodegenerative diseases
Bennett, M. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.010 · Cited by 195 · see citing works
Alpha-synuclein release by neurons activates the inflammatory response in a microglial cell line
Alvarez‐Erviti, L., Couch, Y., Richardson, J. C., Cooper, J. A. D., & Wood, M. J. A. (2011) · Neuroscience Research · doi:10.1016/j.neures.2010.12.020 · Cited by 193 · see citing works
Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation
Chu, K., Lee, S., Sinn, D.-I., Ko, S., Kim, E., Kim, J., Kim, S., Park, D.-K., Jung, K., Song, E., et al. (2006) · Stroke · doi:10.1161/01.str.0000252091.36912.65 · Cited by 188 · see citing works
Total and Specific Polyphenol Intakes in Midlife Are Associated with Cognitive Function Measured 13 Years Later3
Kesse‐Guyot, E., Fezeu, L., Andreeva, V. A., Touvier, M., Scalbert, A., Herçberg, S., & Galan, P. (2011) · Journal of Nutrition · doi:10.3945/jn.111.144428 · Cited by 185 · see citing works
Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo
Reglődi, D., Kiss, P., Lubics, A., et al. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795589355 · Cited by 183 · see citing works
Neuroprotective Effects of Hesperidin, a Plant Flavanone, on Rotenone-Induced Oxidative Stress and Apoptosis in a Cellular Model for Parkinson’s Disease
Tamilselvam, K., Braidy, N., Manivasagam, T., Essa, M. M., Prasad, N. R., Karthikeyan, S., Thenmozhi, A. J., Subash, S., & Guillemin, G. J. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/102741 · Cited by 183 · see citing works
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Russo, I., Bubacco, L., & Greggio, E. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-52 · Cited by 180 · see citing works
AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities inDrosophilaModels of Parkinson's Disease
Ng, C.-H., Guan, M. S. H., Koh, C., Ouyang, X., Yu, F., Tan, E., O’Neill, S., Zhang, X., Chung, J., & Lim, K. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0499-12.2012 · Cited by 177 · see citing works
Science, medicine, and the future: Parkinson's disease.
Schapira, A. (1999) · British medical journal · doi:10.1136/bmj.318.7179.311 · Cited by 174 · see citing works
Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro11Edited by J. Karn
Tagliavini, F., Forloni, G., Colombo, L., Rossi, G., Girola, L., Canciani, B., Angeretti, N., Giampaolo, L., PERESSINI, E., Awan, T., et al. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3840 · Cited by 172 · see citing works
d-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed inXenopus oocytes
Watson, G. B., Bolanowski, M. A., Baganoff, M. P., Deppeler, C. L., & Lanthorn, T. H. (1990) · Brain Research · doi:10.1016/0006-8993(90)90745-w · Cited by 172 · see citing works
Iron and α-Synuclein in the Substantia Nigra of MPTP-Treated Mice: Effect of Neuroprotective Drugs R-Apomorphine and Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate
Mandel, S. A., Maor, G., & Youdim, M. B. H. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:401 · Cited by 171 · see citing works
Doxycycline Alters Metabolism and Proliferation of Human Cell Lines
Ahler, E., Sullivan, W. J., Cass, A. A., Braas, D., York, A. G., Bensinger, S. J., Graeber, T. G., & Christofk, H. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064561 · Cited by 170 · see citing works
Resveratrol Neuroprotection in a Chronic Mouse Model of Multiple Sclerosis
Fonseca-Kelly, Z., Nassrallah, M., Uribe, J., Khan, R. S., Dine, K. E., Dutt, M., & Shindler, K. S. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00084 · Cited by 168 · see citing works
Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease
Ries, V., Henchcliffe, C., Kareva, T., Rzhetskaya, M., Bland, R. J., During, M. J., Kholodilov, N. G., & Burke, R. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606401103 · Cited by 168 · see citing works
Neuropeptides in learning and memory
Borbély, É., Scheich, B., & Helyes, Z. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.012 · Cited by 166 · see citing works
Present and future drug treatment for Parkinson's disease
Schapira, A. H. V. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.035980 · Cited by 165 · see citing works
Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy
Lin, T., Chen, S., Chuang, Y., Lin, H., Huang, C.-R., Chuang, J., Wang, P., Huang, S., Tiao, M., Chen, J., et al. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011625 · Cited by 163 · see citing works
Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols
Camilleri, A., Zarb, C., Caruana, M., Ostermeier, U., Ghio, S., Högen, T., Schmidt, F., Giese, A., & Vassallo, N. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.06.026 · Cited by 161 · see citing works
Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: Possible role of SOCS-1 in reducing pro-inflammatory responses
Lofrumento, D. D., Nicolardi, G., Cianciulli, A., Nuccio, F. D., Pesa, V. L., Carofiglio, V. E., Dragone, T., Calvello, R., & Panaro, M. A. (2013) · Innate Immunity · doi:10.1177/1753425913488429 · Cited by 156 · see citing works
Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals
Henning, S. M., Niu, Y., Liu, Y., Lee, N. H., Hara, Y., Thames, G., Minutti, R. R., Carpenter, C. L., Wang, H., & Heber, D. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.03.003 · Cited by 155 · see citing works
Quercetin and Sesamin Protect Dopaminergic Cells from MPP+-Induced Neuroinflammation in a Microglial (N9)-Neuronal (PC12) Coculture System
Bournival, J., Plouffe, M., Renaud, J., Provencher, C., & Martinoli, M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/921941 · Cited by 150 · see citing works
Self-citation
Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson’s disease
Plaitakis, A., & Shashidharan, P. (2000) · Journal of Neurology · doi:10.1007/pl00007757 · Cited by 142 · see citing works
Amyloid‐beta ( A β1–42)‐induced paralysis in C aenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways
Regitz, C., Dußling, L. M., & Wenzel, U. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400014 · Cited by 142 · see citing works
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia
Delgado, M., Leceta, J., & Ganea, D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0702372 · Cited by 141 · see citing works
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139 · see citing works
Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway
Ye, Q., Ye, L., Xu, X.-J., Huang, B., Zhang, X., Zhu, Y., & Chen, X. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-82 · Cited by 134 · see citing works
Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide inhibit chemokine production in activated microglia
Delgado, M., Jonakait, G. M., & Ganea, D. (2002) · Glia · doi:10.1002/glia.10098 · Cited by 131 · see citing works
Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system
Petrucelli, L., & Dawson, T. M. (2004) · Annals of Medicine · doi:10.1080/07853890410031948 · Cited by 130 · see citing works
Authentically Phosphorylated α-Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's Disease
Sato, H., Arawaka, S., Hara, S., Fukushima, S., Koga, K., Koyama, S., & Kato, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3967-11.2011 · Cited by 127 · see citing works
Repairing the parkinsonian brain with neurotrophic factors
Aron, L., & Klein, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.11.001 · Cited by 126 · see citing works
Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons
Lin, S., Zhang, Y., Dodel, R. C., Farlow, M. R., Paul, S. M., & Du, Y. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02324-2 · Cited by 126 · see citing works
Iron metabolism and Parkinson's disease.
Hirsch, É. C., & Faucheux, B. A. (1998) · PubMed · Cited by 124 · see citing works
Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
Choi, D.-H., Kim, Y.-J., Kim, Y.-G., Joh, T. H., Beal, M. F., & Kim, Y.-S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.222430 · Cited by 123 · see citing works
Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: a study inspired by the physiological roles of PACAP in the brain
Masuo, Y., Morita, M., Oka, S., & Ishido, M. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.05.010 · Cited by 119 · see citing works
Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model
Lazzarini, M., Martin, S., Mitkovski, M., Raisman‐Vozari, R., Stühmer, W., & Bel, E. D. (2013) · Glia · doi:10.1002/glia.22496 · Cited by 119 · see citing works
Self-citation
PACAP is an Endogenous Protective Factor—Insights from PACAP-Deficient Mice
Reglődi, D., Kiss, P., Szabadfi, K., et al. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9762-0 · Cited by 118 · see citing works
Oxidized quercetin inhibits α-synuclein fibrillization
Zhu, M., Han, S., & Fink, A. L. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.12.027 · Cited by 115 · see citing works
Plasma-Kinetic Characteristics of Purified and Isolated Green Tea Catechin Epigallocatechin Gallate (EGCG) after 10 Days Repeated Dosing in Healthy Volunteers
Ullmann, Haller, Decourt, et al. (2004) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.74.4.269 · Cited by 115 · see citing works
Role of matrix metalloproteinase-3 in neurodegeneration
Kim, E., & Hwang, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07082.x · Cited by 114 · see citing works
Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
Liu, K., Shi, N., Sun, Y., Zhang, T., & Sun, X. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0909-8 · Cited by 114 · see citing works
Psychiatric aspects of Parkinson’s disease
Grover, S., Somaiya, M. P., Kumar, S., & Avasthi, A. (2014) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.143197 · Cited by 113 · see citing works
Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity
Han, P., Tang, Z., Yin, J., Maalouf, M., Beach, T. G., Reiman, E. M., & Shi, J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.022 · Cited by 110 · see citing works
Baicalein attenuates astroglial activation in the 1‐methyl‐4‐phenyl‐1,2,3,4‐tetrahydropyridine‐induced Parkinson's disease model by downregulating the activations of nuclear factor‐κB, ERK, and JNK
Lee, E., Park, H. R., Ji, S. T., Lee, Y., & Lee, J. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23307 · Cited by 108 · see citing works
Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats
Haleagrahara, N., Siew, C. J., & Ponnusamy, K. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.25 · Cited by 108 · see citing works
Neuroprotection by Minocycline Caused by Direct and Specific Scavenging of Peroxynitrite
Schildknecht, S., Pape, R., Müller, N., Robotta, M., Marquardt, A., Bürkle, A., Drescher, M., & Leist, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169565 · Cited by 107 · see citing works
The behavioral phenotype of pituitary adenylate-cyclase activating polypeptide-deficient mice in anxiety and depression tests is accompanied by blunted c-Fos expression in the bed nucleus of the stria terminalis, central projecting Edinger–Westphal nucleus, ventral lateral septum, and dorsal raphe nucleus
Gaszner, B., Kormos, V., Kozicz, T., Hashimoto, H., Reglődi, D., & Helyes, Z. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.046 · Cited by 106 · see citing works
Concentrations of pituitary adenylate cyclase activating polypeptide (PACAP) in human brain nuclei
Palkovits, M., Somogyvári-Vigh, A., & Arimura, A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00869-r · Cited by 104 · see citing works
Antibacterial and Antitumorigenic Properties of Microcin E492, a Pore- Forming Bacteriocin
Lagos, R., Tello, M., Mercado, G., Garcia, V., & Monasterio, O. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048643 · Cited by 104 · see citing works
Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys
Chen, M., Wang, T., Yue, F., Li, X., Wang, P., Li, Y., Chan, P., & Yu, S. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.003 · Cited by 103 · see citing works
Anti-Parkinsonian drug discovery from herbal medicines: What have we got from neurotoxic models?
Song, J., Sze, S. C. W., Ng, T., Lee, C., Leung, G., Shaw, P., Tong, Y., & Zhang, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.030 · Cited by 102 · see citing works
Delayed Pituitary Adenylate Cyclase–Activating Polypeptide Delivery After Brain Stroke Improves Functional Recovery by Inducing M2 Microglia/Macrophage Polarization
Brifault, C., Gras, M., Liot, D., May, V., Vaudry, D., & Wurtz, O. (2014) · Stroke · doi:10.1161/strokeaha.114.006864 · Cited by 102 · see citing works
Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson’s disease
JIANG, J., Jiang, J., Zuo, Y., & Gu, Z. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1280 · Cited by 101 · see citing works
Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease
Onyango, I. G. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9482-y · Cited by 100 · see citing works
Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson’s disease
Reglődi, D., Lubics, A., Tamás, A., et al. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.09.007 · Cited by 100 · see citing works
Translational regulation in cell stress and apoptosis. Roles of the eIF4E binding proteins
Clemens, M. J. (2001) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2001.tb00157.x · Cited by 98 · see citing works
Advances in non-dopaminergic treatments for Parkinson's disease
Stayte, S., & Vissel, B. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00113 · Cited by 98 · see citing works
Rutin from Dendropanax morbifera Leveille Protects Human Dopaminergic Cells Against Rotenone Induced Cell Injury Through Inhibiting JNK and p38 MAPK Signaling
Park, S., Sapkota, K., Choi, J., et al. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1259-5 · Cited by 95 · see citing works
Exogenous Administration of PACAP Alleviates Traumatic Brain Injury in Rats through a Mechanism Involving the TLR4/MyD88/NF-κB Pathway
Mao, S., Hua, R., Zhao, X., Qin, X., Sun, Z.-Q., Zhang, Y., Wu, Y.-Q., Jia, M., Cao, J., & Zhang, Y.-M. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2244 · Cited by 93 · see citing works
Management of Parkinson׳s disease: Current and future pharmacotherapy
Kakkar, A. K., & Dahiya, N. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.030 · Cited by 92 · see citing works
Deficit of NMDA receptor activation in CA1 hippocampal area of aged rats is rescued by d ‐cycloserine
Billard, J., & Rouaud, E. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05488.x · Cited by 91 · see citing works
Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson’s disease mice
Kavitha, M., Nataraj, J., Essa, M. M., Memon, M. A., & Manivasagam, T. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.09.016 · Cited by 91 · see citing works
Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
Bi, W., Zhu, L., Wang, C., Liang, Y., Liu, J., Shi, Q., & Tao, E. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.019 · Cited by 91 · see citing works
The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury
Wei, J., Pan, X.-D., Pei, Z., Wang, W., Qiu, W., Shi, Z., & Xiao, G. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31825133c0 · Cited by 90 · see citing works
Effect of Curcumin on Lifespan, Activity Pattern, Oxidative Stress, and Apoptosis in the Brains of Transgenic Drosophila Model of Parkinson’s Disease
Siddique, Y. H., Naz, F., & Jyoti, S. (2014) · BioMed Research International · doi:10.1155/2014/606928 · Cited by 90 · see citing works
Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
Esteves, A. R., Arduíno, D. M., Silva, D. F., Oliveira, C. R., & Cardoso, S. M. (2011) · Parkinson s Disease · doi:10.4061/2011/693761 · Cited by 89 · see citing works
A new face for old antibiotics: tetracyclines in treatment of amyloidoses.
Stoilova, T., Colombo, L., Forloni, G., Tagliavini, F., & Salmona, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400161p · Cited by 89 · see citing works
Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol
Khan, M. M., Kempuraj, D., Thangavel, R., & Zaheer, A. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.029 · Cited by 88 · see citing works
Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia
Jantaratnotai, N., Utaisincharoen, P., Sanvarinda, P., Thampithak, A., & Sanvarinda, Y. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.07.013 · Cited by 85 · see citing works
Parkinson's disease and age: The obvious but largely unexplored link
Abdullah, R., Basak, I., Patil, K. S., Alves, G. W., Larsen, J. P., & Møller, S. G. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.014 · Cited by 85 · see citing works
Doxycycline Is Neuroprotective Against Nigral Dopaminergic Degeneration by a Dual Mechanism Involving MMP-3
Cho, Y., Son, H. J., Kim, E.-M., Choi, J. H., Kim, S. T., Ji, I. J., Choi, D. H., Joh, T. H., Kim, Y. S., & Hwang, O. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9078-1 · Cited by 85 · see citing works
Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis
Minagar, A., Alexander, J. S., Schwendimann, R. N., Kelley, R. E., Gonzalez‐Toledo, E., Jimenez, J. J., Mauro, L., Jy, W., & Smith, S. J. (2007) · Archives of Neurology · doi:10.1001/archneurol.2007.41 · Cited by 84 · see citing works
Effect of IGF‐1 on the balance between autophagy of dysfunctional mitochondria and apoptosis
Gu, Y., Wang, C., & Cohen, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.040 · Cited by 84 · see citing works
Neuroprotective Effects of Puerarin on 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine induced Parkinson's Disease Model in Mice
Zhu, G., Wang, X., Wu, S.-B., Li, X., & Li, Q. (2013) · Phytotherapy Research · doi:10.1002/ptr.4975 · Cited by 83 · see citing works
Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease
Pérez-H, J., Carrillo-Salgado, C., Garcı́a, E., Ruiz-Mar, G., Pérez-Tamayo, R., & Chavarría, A. (2014) · Toxicology · doi:10.1016/j.tox.2014.02.009 · Cited by 83 · see citing works
PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone
Wang, G., Chen, Q., Fan, G.-H., Zhou, H., & Chen, S. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.013 · Cited by 83 · see citing works
Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury
Cui, C., Cui, Y., Gao, J., Sun, L., Wang, Y., Wang, R. C., Li, R., Tian, Y., Song, S., & Cui, J. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1585-4 · Cited by 83 · see citing works
Isolation of Peptide Transport System-6 from Brain Endothelial Cells: Therapeutic Effects with Antisense Inhibition in Alzheimer and Stroke Models
Doğrukol‐Ak, D., Kumar, V. B., Ryerse, J. S., Farr, S. A., Verma, S., Nonaka, N., Nakamachi, T., Ohtaki, H., Niehoff, M. L., Edwards, J. C., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.131 · Cited by 81 · see citing works
In Vitro Antioxidant Activities of Three Red Wine Polyphenols and Their Mixtures: An Interaction Study
Kurin, E., Mučaji, P., & Nagy, M. (2012) · Molecules · doi:10.3390/molecules171214336 · Cited by 81 · see citing works
Peroxynitrite Modulates the Activation of p38 and Extracellular Regulated Kinases in PC12 Cells
Jope, R. S., Zhang, L., & Song, L. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1728 · Cited by 80 · see citing works
Ceftriaxone Ameliorates Motor Deficits and Protects Dopaminergic Neurons in 6-Hydroxydopamine-Lesioned Rats
Leung, T. C. H., Lui, C. N. P., Chen, L. W., Yung, W. H., Chan, Y. S., & Yung, K. K. L. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200072h · Cited by 78 · see citing works
Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice
Deguil, J., Chavant, F., Lafay-Chebassier, C., Pérault-Pochat, M., Fauconneau, B., & Pain, S. (2010) · Neurotoxicity research · doi:10.1007/s12640-009-9091-4 · Cited by 77 · see citing works
Neuroprotective roles of pituitary adenylate cyclase-activating polypeptide in neurodegenerative diseases
Lee, E. H., & Seo, S. R. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.7.086 · Cited by 75 · see citing works
Effect of PACAP in Central and Peripheral Nerve Injuries
Tamas, A., Reglodi, D., Farkas, O., Kovesdi, E., Pal, J., Povlishock, J., Schwarcz, A., Czeiter, E., Szántó, Z., Dóczi, T., et al. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078430 · Cited by 75 · see citing works
Self-citation
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) 38 and PACAP4–6 Are Neuroprotective through Inhibition of NADPH Oxidase: Potent Regulators of Microglia-Mediated Oxidative Stress
Yang, S., Yang, J. H., Yang, Z., Chen, P., Fraser, A., Zhang, W., Pang, H., Gao, X., Wilson, B. C., Hong, J., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.102236 · Cited by 74 · see citing works
Therapeutic Attenuation of Neuroinflammation and Apoptosis by Black Tea Theaflavin in Chronic MPTP/Probenecid Model of Parkinson’s Disease
Anandhan, A., Essa, M. M., & Manivasagam, T. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9332-9 · Cited by 73 · see citing works
Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells
Kato, H., Ito, A., Kawanokuchi, J., Jin, S., Mizuno, T., Ojika, K., Ueda, R., & Suzumura, A. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1096oa · Cited by 73 · see citing works
Effects of d-cycloserine on MPTP-induced behavioral and neurological changes: Potential for treatment of Parkinson's disease dementia
Ho, Y., Ho, S.-C., Pawlak, C. R., & Yeh, K.-Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.028 · Cited by 72 · see citing works
Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP+ injection in rats
Geed, M., Garabadu, D., Ahmad, A., & Krishnamurthy, S. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.008 · Cited by 71 · see citing works
Ceftriaxone Blocks the Polymerization of α-Synuclein and Exerts Neuroprotective Effects in Vitro
Ruzza, P., Siligardi, G., Hussain, R., Marchiani, A., Islami, M., Bubacco, L., Delogu, G., Fabbri, D., Dettori, M. A., Sechi, M., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400149k · Cited by 70 · see citing works
Pinocembrin Attenuates 6-OHDA-induced Neuronal Cell Death Through Nrf2/ARE Pathway in SH-SY5Y Cells
Jin, X., Liu, Q., Jia, L., Li, M., & Wang, X. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0128-8 · Cited by 69 · see citing works
Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding
Noble, W. J., Garwood, C. J., & Hanger, D. P. (2009) · Prion · doi:10.4161/pri.3.2.8820 · Cited by 67 · see citing works
Matrix Metalloproteinase-9 Is Elevated in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinsonism in Mice
Lorenzl, S., Calingasan, N. Y., Yang, L., Albers, D. S., Shugama, S., Gregorio, J., Krell, H. W., Chirichigno, J. W., JOH, T. H., & Beal, M. F. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:2:119 · Cited by 67 · see citing works
Protective Effects of Curcumin Against Rotenone and Salsolinol-Induced Toxicity: Implications for Parkinson’s Disease
Qualls, Z., Brown, D., Ramlochansingh, C., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9433-0 · Cited by 66 · see citing works
Effects of Ceftriaxone on the Behavioral and Neuronal Changes in an MPTP-Induced Parkinson’s Disease Rat Model
Ho, S.-C., Hsu, C.-C., Pawlak, C. R., Tikhonova, M. A., Lai, T.-J., Amstislavskaya, T. G., & Ho, Y.-J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.022 · Cited by 65 · see citing works
Resveratrol Confers Protection against Rotenone-Induced Neurotoxicity by Modulating Myeloperoxidase Levels in Glial Cells
Chang, C. Y., Choi, D., Lee, D., Hong, Y. J., & Park, E. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060654 · Cited by 65 · see citing works
Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and maneb and paraquat mice models of Parkinson's disease
Dixit, A., Srivastava, G., Verma, D., Mishra, M., Singh, P. K., Prakash, O., & Singh, M. P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.019 · Cited by 64 · see citing works
Pituitary adenylate cyclase–activating polypeptide is reduced in Alzheimer disease
Han, P., Liang, W. S., Baxter, L. C., Yin, J., Tang, Z., Beach, T. G., Caselli, R. J., Reiman, E. M., & Shi, J. (2014) · Neurology · doi:10.1212/wnl.0000000000000417 · Cited by 64 · see citing works
Polyphenolic compounds are novel protective agents against lipid membrane damage by α-synuclein aggregates in vitro
Caruana, M., Neuner, J., Högen, T., Schmidt, F., Kamp, F., Scerri, C., Giese, A., & Vassallo, N. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.05.019 · Cited by 64 · see citing works
Decreased beta-amyloid and increased abnormal Tau deposition in the brain of aged patients with leprosy.
Chui, D., Tabira, T., Izumi, S., Koya, G., & Ogata, J. (1994) · PubMed Central · Cited by 63 · see citing works
PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity
Guillot, T. S., Richardson, J. R., Wang, M. Z., Li, Y. J., Taylor, T. N., Ciliax, B. J., Zachrisson, O., Mercer, A., & Miller, G. W. (2008) · Neuropeptides · doi:10.1016/j.npep.2008.04.003 · Cited by 63 · see citing works
PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action
Dejda, A., Seaborn, T., Bourgault, S., et al. (2011) · Peptides · doi:10.1016/j.peptides.2011.04.003 · Cited by 62 · see citing works
Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats
Bisht, R., Kaur, B., Gupta, H., & Prakash, A. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.05.009 · Cited by 62 · see citing works
Neuroprotective Effect of PACAP Against NMDA-Induced Retinal Damage in the Mouse
Endo, K., Nakamachi, T., Seki, T., et al. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9434-x · Cited by 62 · see citing works

Flagged first, then by citations

Research works printed but not linked: 1

Eiden, L.E., 2012. PACAP and cellular protection. In: Neuropeptide in Neuroprotec- tion and NeuroregenerationCRC Press, Boca Raton, FL, pp. 179-208.

Sorted by citations

Dysbiosis of gut microbiota and microbial metabolites in Parkinson's disease
Sun, M.-F., & Shen, Y.-Q. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.004 · Cited by 445 · see citing works
Doxycycline Inhibits α-Synuclein-Associated Pathologies in Vitro and in Vivo
Dominguez-Meijide, A., Parrales, V., Vasili, E., González-Lizárraga, F., König, A., Lázaro, D. F., Lannuzel, A., Haik, S., Del Bel, E., Chehín, R., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105256 · Cited by 81 · see citing works
Self-citation
The neuroprotective effect of doxycycline on neurodegenerative diseases
Santa-Cecília, F. V., Leite, C. A., Del-Bel, E., & Raisman-Vozari, R. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00015-z · Cited by 73 · see citing works
Self-citation
New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69 · see citing works
Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis
Hong, D., Zhang, C., Wu, W., Lu, X., & Zhang, L. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1133546 · Cited by 38 · see citing works
The antibiotic doxycycline mimics the NGF signaling in PC12 cells: A relevant mechanism for neuroprotection
Amaral, L. D., Santos, N. A. G. D., Sisti, F. M., Del Bel, E., & Santos, A. C. D. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109454 · Cited by 18 · see citing works
Self-citation

Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019
Shir, D., & Day, G. S. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001033 · Cited by 13 · see citing works
Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration
Niranjan, R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.003 · Cited by 112 · see citing works
Review paper Neurogenesis and neuroprotection in postischemic brain neurodegeneration with Alzheimer phenotype: is there a role for curcumin?
Pluta, R., Bogucka-Kocka, A., Ułamek-Kozioł, M., Furmaga-Jabłońska, W., Januszewski, S., Brzozowska, J., Jabłoński, M., & Kocki, J. (2015) · Folia Neuropathologica · doi:10.5114/fn.2015.52405 · Cited by 34 · see citing works
Mitochondria and the Link Between Neuroinflammation and Neurodegeneration
Filippo, M. D., Chiasserini, D., Tozzi, A., Picconi, B., & Calabresi, P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100543 · Cited by 155 · see citing works
Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
Batista, C. R. A., Gomes, G. F., Candelario-Jalil, E., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092293 · Cited by 529 · see citing works

Authors: Reglodi, D., Renaud, J., Tamas, A., Tizabi, Y., Socías, S. B., Del-Bel, E., & Raisman-Vozari, R.
Affiliations: Université du Québec (CA)
Howard University (US)
National University of Tucumán (AR)
ORCID: Renaud, Justine
Tizabi, Yousef
Socías, Sergio B.
Venue: Progress in Neurobiology
Publisher: Elsevier BV
Published: 2017-08
Volume: 155
Pages: 120-148
ISSN: 0301-0082 (ISSN-L)
DOI: 10.1016/j.pneurobio.2015.10.004
OpenAlex: W2134296216
Cited by: 162
References: 306
Citations by year: 2026: 6 · 2025: 6 · 2024: 8 · 2023: 10 · 2022: 15 · 2021: 19 · 2020: 23 · 2019: 21 · 2018: 18 · 2017: 17 · 2016: 16 · 2015: 2
FWCI: 2.33
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Progress in Neurobiology (publishedVersion)
PubMed (publishedVersion)
Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
Funders: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq402658/2012-4)
Topics: Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords: Parkinson's disease, neuroprotection, polyphenols, antibiotics, neuropeptides, PACAP, alpha-synuclein oligomers, mitochondrial dysfunction, neuroinflammation, oxidative stress, protein misfolding, dopaminergic neurons, anti-apoptotic effects
MeSH terms: Neuroprotection, Animals, Anti-Bacterial Agents, Brain, Humans, Neuropeptides, Parkinson Disease, Neuroprotective Agents, Polyphenols

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks